nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosamprenavir—CYP3A4—Rosuvastatin—atherosclerosis	0.152	0.211	CbGbCtD
Fosamprenavir—CYP3A4—Ezetimibe—atherosclerosis	0.152	0.211	CbGbCtD
Fosamprenavir—CYP3A4—Simvastatin—atherosclerosis	0.141	0.196	CbGbCtD
Fosamprenavir—CYP3A4—Pravastatin—atherosclerosis	0.138	0.192	CbGbCtD
Fosamprenavir—CYP3A4—Lovastatin—atherosclerosis	0.138	0.192	CbGbCtD
Fosamprenavir—Myositis—Rosuvastatin—atherosclerosis	0.0115	0.0411	CcSEcCtD
Fosamprenavir—Rhabdomyolysis—Rosuvastatin—atherosclerosis	0.00637	0.0228	CcSEcCtD
Fosamprenavir—Rhabdomyolysis—Lovastatin—atherosclerosis	0.0054	0.0193	CcSEcCtD
Fosamprenavir—Rhabdomyolysis—Ezetimibe—atherosclerosis	0.0053	0.019	CcSEcCtD
Fosamprenavir—Gastrooesophageal reflux disease—Ezetimibe—atherosclerosis	0.00519	0.0186	CcSEcCtD
Fosamprenavir—Rhabdomyolysis—Simvastatin—atherosclerosis	0.00505	0.0181	CcSEcCtD
Fosamprenavir—Inflammation—Ezetimibe—atherosclerosis	0.00483	0.0173	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Rosuvastatin—atherosclerosis	0.00471	0.0168	CcSEcCtD
Fosamprenavir—Rhabdomyolysis—Niacin—atherosclerosis	0.00464	0.0166	CcSEcCtD
Fosamprenavir—Inflammation—Simvastatin—atherosclerosis	0.00461	0.0165	CcSEcCtD
Fosamprenavir—Rhabdomyolysis—Pravastatin—atherosclerosis	0.00457	0.0163	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Simvastatin—atherosclerosis	0.00373	0.0134	CcSEcCtD
Fosamprenavir—Diabetes mellitus—Niacin—atherosclerosis	0.00342	0.0123	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.00306	0.011	CcSEcCtD
Fosamprenavir—Gastritis—Ezetimibe—atherosclerosis	0.00301	0.0108	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.003	0.0107	CcSEcCtD
Fosamprenavir—Gastritis—Simvastatin—atherosclerosis	0.00287	0.0103	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00265	0.00949	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00259	0.00926	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00248	0.00887	CcSEcCtD
Fosamprenavir—Flatulence—Rosuvastatin—atherosclerosis	0.00243	0.00869	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00231	0.00828	CcSEcCtD
Fosamprenavir—Erythema multiforme—Lovastatin—atherosclerosis	0.00227	0.00812	CcSEcCtD
Fosamprenavir—Angioedema—Rosuvastatin—atherosclerosis	0.00225	0.00806	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00224	0.00802	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00223	0.00798	CcSEcCtD
Fosamprenavir—Erythema multiforme—Ezetimibe—atherosclerosis	0.00223	0.00796	CcSEcCtD
Fosamprenavir—Myocardial infarction—Pravastatin—atherosclerosis	0.00222	0.00793	CcSEcCtD
Fosamprenavir—Immune system disorder—Ezetimibe—atherosclerosis	0.00213	0.00761	CcSEcCtD
Fosamprenavir—Erythema multiforme—Simvastatin—atherosclerosis	0.00212	0.0076	CcSEcCtD
Fosamprenavir—Myalgia—Rosuvastatin—atherosclerosis	0.0021	0.00751	CcSEcCtD
Fosamprenavir—Haemoglobin—Niacin—atherosclerosis	0.00207	0.00741	CcSEcCtD
Fosamprenavir—Haemorrhage—Niacin—atherosclerosis	0.00206	0.00738	CcSEcCtD
Fosamprenavir—Flatulence—Lovastatin—atherosclerosis	0.00206	0.00737	CcSEcCtD
Fosamprenavir—Malnutrition—Ezetimibe—atherosclerosis	0.00205	0.00733	CcSEcCtD
Fosamprenavir—Flatulence—Ezetimibe—atherosclerosis	0.00202	0.00723	CcSEcCtD
Fosamprenavir—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00197	0.00706	CcSEcCtD
Fosamprenavir—Flatulence—Simvastatin—atherosclerosis	0.00193	0.00689	CcSEcCtD
Fosamprenavir—Erythema multiforme—Pravastatin—atherosclerosis	0.00192	0.00687	CcSEcCtD
Fosamprenavir—Angioedema—Lovastatin—atherosclerosis	0.00191	0.00683	CcSEcCtD
Fosamprenavir—Cardiac disorder—Pravastatin—atherosclerosis	0.00188	0.00674	CcSEcCtD
Fosamprenavir—Angioedema—Ezetimibe—atherosclerosis	0.00187	0.0067	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00183	0.00656	CcSEcCtD
Fosamprenavir—Malnutrition—Niacin—atherosclerosis	0.00179	0.00642	CcSEcCtD
Fosamprenavir—Angioedema—Simvastatin—atherosclerosis	0.00179	0.00639	CcSEcCtD
Fosamprenavir—Myalgia—Lovastatin—atherosclerosis	0.00178	0.00637	CcSEcCtD
Fosamprenavir—Flatulence—Niacin—atherosclerosis	0.00177	0.00633	CcSEcCtD
Fosamprenavir—Myalgia—Ezetimibe—atherosclerosis	0.00174	0.00624	CcSEcCtD
Fosamprenavir—Flatulence—Pravastatin—atherosclerosis	0.00174	0.00623	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00173	0.0062	CcSEcCtD
Fosamprenavir—Myalgia—Simvastatin—atherosclerosis	0.00166	0.00595	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00164	0.00589	CcSEcCtD
Fosamprenavir—Nervous system disorder—Ezetimibe—atherosclerosis	0.00164	0.00587	CcSEcCtD
Fosamprenavir—Angioedema—Niacin—atherosclerosis	0.00164	0.00587	CcSEcCtD
Fosamprenavir—Anorexia—Lovastatin—atherosclerosis	0.00162	0.00582	CcSEcCtD
Fosamprenavir—Skin disorder—Ezetimibe—atherosclerosis	0.00162	0.00581	CcSEcCtD
Fosamprenavir—Angioedema—Pravastatin—atherosclerosis	0.00161	0.00578	CcSEcCtD
Fosamprenavir—Abdominal pain—Rosuvastatin—atherosclerosis	0.00159	0.00569	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00155	0.00556	CcSEcCtD
Fosamprenavir—Myalgia—Niacin—atherosclerosis	0.00153	0.00547	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00152	0.00545	CcSEcCtD
Fosamprenavir—Anorexia—Simvastatin—atherosclerosis	0.00152	0.00544	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00152	0.00543	CcSEcCtD
Fosamprenavir—Myalgia—Pravastatin—atherosclerosis	0.0015	0.00538	CcSEcCtD
Fosamprenavir—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00148	0.0053	CcSEcCtD
Fosamprenavir—Decreased appetite—Lovastatin—atherosclerosis	0.00148	0.0053	CcSEcCtD
Fosamprenavir—Fatigue—Lovastatin—atherosclerosis	0.00147	0.00526	CcSEcCtD
Fosamprenavir—Decreased appetite—Ezetimibe—atherosclerosis	0.00145	0.0052	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00145	0.0052	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00144	0.00517	CcSEcCtD
Fosamprenavir—Asthenia—Rosuvastatin—atherosclerosis	0.00144	0.00517	CcSEcCtD
Fosamprenavir—Fatigue—Ezetimibe—atherosclerosis	0.00144	0.00516	CcSEcCtD
Fosamprenavir—Pruritus—Rosuvastatin—atherosclerosis	0.00142	0.00509	CcSEcCtD
Fosamprenavir—Skin disorder—Niacin—atherosclerosis	0.00142	0.00509	CcSEcCtD
Fosamprenavir—Anorexia—Niacin—atherosclerosis	0.0014	0.005	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00139	0.00499	CcSEcCtD
Fosamprenavir—Decreased appetite—Simvastatin—atherosclerosis	0.00139	0.00496	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00138	0.00493	CcSEcCtD
Fosamprenavir—Diarrhoea—Rosuvastatin—atherosclerosis	0.00138	0.00493	CcSEcCtD
Fosamprenavir—Fatigue—Simvastatin—atherosclerosis	0.00137	0.00492	CcSEcCtD
Fosamprenavir—Anorexia—Pravastatin—atherosclerosis	0.00137	0.00492	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00137	0.00489	CcSEcCtD
Fosamprenavir—Body temperature increased—Lovastatin—atherosclerosis	0.00135	0.00482	CcSEcCtD
Fosamprenavir—Abdominal pain—Lovastatin—atherosclerosis	0.00135	0.00482	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00133	0.00477	CcSEcCtD
Fosamprenavir—Dizziness—Rosuvastatin—atherosclerosis	0.00133	0.00476	CcSEcCtD
Fosamprenavir—Body temperature increased—Ezetimibe—atherosclerosis	0.00132	0.00473	CcSEcCtD
Fosamprenavir—Abdominal pain—Ezetimibe—atherosclerosis	0.00132	0.00473	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00131	0.0047	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Simvastatin—atherosclerosis	0.0013	0.00467	CcSEcCtD
Fosamprenavir—Decreased appetite—Niacin—atherosclerosis	0.00127	0.00456	CcSEcCtD
Fosamprenavir—Rash—Rosuvastatin—atherosclerosis	0.00127	0.00454	CcSEcCtD
Fosamprenavir—Dermatitis—Rosuvastatin—atherosclerosis	0.00127	0.00454	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Niacin—atherosclerosis	0.00126	0.00452	CcSEcCtD
Fosamprenavir—Body temperature increased—Simvastatin—atherosclerosis	0.00126	0.00451	CcSEcCtD
Fosamprenavir—Abdominal pain—Simvastatin—atherosclerosis	0.00126	0.00451	CcSEcCtD
Fosamprenavir—Headache—Rosuvastatin—atherosclerosis	0.00126	0.00451	CcSEcCtD
Fosamprenavir—Hypersensitivity—Lovastatin—atherosclerosis	0.00126	0.0045	CcSEcCtD
Fosamprenavir—Decreased appetite—Pravastatin—atherosclerosis	0.00125	0.00449	CcSEcCtD
Fosamprenavir—Fatigue—Pravastatin—atherosclerosis	0.00124	0.00445	CcSEcCtD
Fosamprenavir—Hypersensitivity—Ezetimibe—atherosclerosis	0.00123	0.00441	CcSEcCtD
Fosamprenavir—Asthenia—Lovastatin—atherosclerosis	0.00122	0.00438	CcSEcCtD
Fosamprenavir—Pruritus—Lovastatin—atherosclerosis	0.00121	0.00432	CcSEcCtD
Fosamprenavir—Asthenia—Ezetimibe—atherosclerosis	0.0012	0.00429	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Niacin—atherosclerosis	0.0012	0.00429	CcSEcCtD
Fosamprenavir—Nausea—Rosuvastatin—atherosclerosis	0.00119	0.00428	CcSEcCtD
Fosamprenavir—Pruritus—Ezetimibe—atherosclerosis	0.00118	0.00423	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00118	0.00422	CcSEcCtD
Fosamprenavir—Hypersensitivity—Simvastatin—atherosclerosis	0.00117	0.0042	CcSEcCtD
Fosamprenavir—Diarrhoea—Lovastatin—atherosclerosis	0.00117	0.00417	CcSEcCtD
Fosamprenavir—Abdominal pain—Niacin—atherosclerosis	0.00116	0.00414	CcSEcCtD
Fosamprenavir—Body temperature increased—Niacin—atherosclerosis	0.00116	0.00414	CcSEcCtD
Fosamprenavir—Asthenia—Simvastatin—atherosclerosis	0.00114	0.00409	CcSEcCtD
Fosamprenavir—Diarrhoea—Ezetimibe—atherosclerosis	0.00114	0.00409	CcSEcCtD
Fosamprenavir—Abdominal pain—Pravastatin—atherosclerosis	0.00114	0.00408	CcSEcCtD
Fosamprenavir—Body temperature increased—Pravastatin—atherosclerosis	0.00114	0.00408	CcSEcCtD
Fosamprenavir—Pruritus—Simvastatin—atherosclerosis	0.00113	0.00404	CcSEcCtD
Fosamprenavir—Dizziness—Lovastatin—atherosclerosis	0.00113	0.00403	CcSEcCtD
Fosamprenavir—Dizziness—Ezetimibe—atherosclerosis	0.00111	0.00396	CcSEcCtD
Fosamprenavir—Diarrhoea—Simvastatin—atherosclerosis	0.00109	0.00391	CcSEcCtD
Fosamprenavir—Vomiting—Lovastatin—atherosclerosis	0.00108	0.00388	CcSEcCtD
Fosamprenavir—Hypersensitivity—Niacin—atherosclerosis	0.00108	0.00386	CcSEcCtD
Fosamprenavir—Rash—Lovastatin—atherosclerosis	0.00107	0.00385	CcSEcCtD
Fosamprenavir—Dermatitis—Lovastatin—atherosclerosis	0.00107	0.00384	CcSEcCtD
Fosamprenavir—Headache—Lovastatin—atherosclerosis	0.00107	0.00382	CcSEcCtD
Fosamprenavir—Vomiting—Ezetimibe—atherosclerosis	0.00106	0.00381	CcSEcCtD
Fosamprenavir—Hypersensitivity—Pravastatin—atherosclerosis	0.00106	0.0038	CcSEcCtD
Fosamprenavir—Dizziness—Simvastatin—atherosclerosis	0.00105	0.00377	CcSEcCtD
Fosamprenavir—Rash—Ezetimibe—atherosclerosis	0.00105	0.00377	CcSEcCtD
Fosamprenavir—Dermatitis—Ezetimibe—atherosclerosis	0.00105	0.00377	CcSEcCtD
Fosamprenavir—Asthenia—Niacin—atherosclerosis	0.00105	0.00376	CcSEcCtD
Fosamprenavir—Headache—Ezetimibe—atherosclerosis	0.00105	0.00375	CcSEcCtD
Fosamprenavir—Pruritus—Niacin—atherosclerosis	0.00104	0.00371	CcSEcCtD
Fosamprenavir—Asthenia—Pravastatin—atherosclerosis	0.00103	0.0037	CcSEcCtD
Fosamprenavir—Pruritus—Pravastatin—atherosclerosis	0.00102	0.00365	CcSEcCtD
Fosamprenavir—Vomiting—Simvastatin—atherosclerosis	0.00101	0.00363	CcSEcCtD
Fosamprenavir—Nausea—Lovastatin—atherosclerosis	0.00101	0.00362	CcSEcCtD
Fosamprenavir—Rash—Simvastatin—atherosclerosis	0.00101	0.0036	CcSEcCtD
Fosamprenavir—Dermatitis—Simvastatin—atherosclerosis	0.001	0.0036	CcSEcCtD
Fosamprenavir—Diarrhoea—Niacin—atherosclerosis	0.001	0.00359	CcSEcCtD
Fosamprenavir—Headache—Simvastatin—atherosclerosis	0.000999	0.00358	CcSEcCtD
Fosamprenavir—Nausea—Ezetimibe—atherosclerosis	0.000993	0.00355	CcSEcCtD
Fosamprenavir—Diarrhoea—Pravastatin—atherosclerosis	0.000986	0.00353	CcSEcCtD
Fosamprenavir—Dizziness—Niacin—atherosclerosis	0.000968	0.00347	CcSEcCtD
Fosamprenavir—Dizziness—Pravastatin—atherosclerosis	0.000953	0.00341	CcSEcCtD
Fosamprenavir—Nausea—Simvastatin—atherosclerosis	0.000947	0.00339	CcSEcCtD
Fosamprenavir—Vomiting—Niacin—atherosclerosis	0.000931	0.00333	CcSEcCtD
Fosamprenavir—Rash—Niacin—atherosclerosis	0.000923	0.0033	CcSEcCtD
Fosamprenavir—Dermatitis—Niacin—atherosclerosis	0.000922	0.0033	CcSEcCtD
Fosamprenavir—Headache—Niacin—atherosclerosis	0.000917	0.00328	CcSEcCtD
Fosamprenavir—Vomiting—Pravastatin—atherosclerosis	0.000917	0.00328	CcSEcCtD
Fosamprenavir—Rash—Pravastatin—atherosclerosis	0.000909	0.00325	CcSEcCtD
Fosamprenavir—Dermatitis—Pravastatin—atherosclerosis	0.000908	0.00325	CcSEcCtD
Fosamprenavir—Headache—Pravastatin—atherosclerosis	0.000903	0.00323	CcSEcCtD
Fosamprenavir—Nausea—Niacin—atherosclerosis	0.00087	0.00311	CcSEcCtD
Fosamprenavir—Nausea—Pravastatin—atherosclerosis	0.000856	0.00306	CcSEcCtD
